Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
04 2021
Historique:
revised: 06 11 2020
received: 05 06 2020
accepted: 03 12 2020
pubmed: 17 1 2021
medline: 2 7 2021
entrez: 16 1 2021
Statut: ppublish

Résumé

In peripartum cardiomyopathy (PPCM), electrocardiography (ECG) and its relationship to echocardiography have not yet been investigated in large multi-centre and multi-ethnic studies. We aimed to identify ECG abnormalities associated with PPCM, including regional and ethnic differences, and their correlation with echocardiographic features. We studied 411 patients from the EURObservational PPCM registry. Baseline demographic, clinical, and echocardiographic data were collected. ECGs were analysed for rate, rhythm, QRS width and morphology, and QTc interval. The median age was 31 [interquartile range (IQR) 26-35] years. The ECG was abnormal in > 95% of PPCM patients. Sinus tachycardia (heart rate > 100 b.p.m.) was common (51%), but atrial fibrillation was rare (2.27%). Median QRS width was 82 ms [IQR 80-97]. Left bundle branch block (LBBB) was reported in 9.30%. Left ventricular (LV) hypertrophy (LVH), as per ECG criteria, was more prevalent amongst Africans (59.62%) and Asians (23.17%) than Caucasians (7.63%, P < 0.001) but did not correlate with LVH on echocardiography. Median LV end-diastolic diameter (LVEDD) was 60 mm [IQR 55-65] and LV ejection fraction (LVEF) 32.5% [IQR 25-39], with no significant regional or ethnic differences. Sinus tachycardia was associated with an LVEF < 35% (OR 1.85 [95% CI 1.20-2.85], P = 0.006). ECG features that predicted an LVEDD > 55 mm included a QRS complex > 120 ms (OR 11.32 [95% CI 1.52-84.84], P = 0.018), LBBB (OR 4.35 [95% CI 1.30-14.53], P = 0.017), and LVH (OR 2.03 [95% CI 1.13-3.64], P = 0.017). PPCM patients often have ECG abnormalities. Sinus tachycardia predicted poor systolic function, whereas wide QRS, LBBB, and LVH were associated with LV dilatation.

Identifiants

pubmed: 33453082
doi: 10.1002/ehf2.13172
pmc: PMC8006717
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

879-889

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Eur J Heart Fail. 2018 Mar;20(3):445-459
pubmed: 29333691
J Am Coll Cardiol. 2010 Feb 16;55(7):654-9
pubmed: 20170791
Arch Mal Coeur Vaiss. 2004 Jan;97(1):25-30
pubmed: 15002707
Int J Cardiol. 2016 Aug 1;216:165-7
pubmed: 27156059
Eur J Heart Fail. 2017 Sep;19(9):1131-1141
pubmed: 28271625
Br J Sports Med. 2012 Apr;46(5):341-7
pubmed: 21596717
JACC Clin Electrophysiol. 2019 Jan;5(1):113-119
pubmed: 30678775
Eur J Heart Fail. 2014 May;16(5):583-91
pubmed: 24591060
Circulation. 2016 Mar 22;133(12):1199-208
pubmed: 27002082
J Am Coll Cardiol. 2009 Mar 17;53(11):992-1002
pubmed: 19281932
Lancet. 2014 Sep 13;384(9947):980-1004
pubmed: 24797575
J Am Coll Cardiol. 2000 Mar 1;35(3):701-5
pubmed: 10716473
J Obstet Gynaecol Can. 2017 Sep;39(9):728-733.e3
pubmed: 28566256
Br J Gen Pract. 2006 Jan;56(522):48-56
pubmed: 16438815
Am J Cardiol. 2004 Jan 15;93(2):244-6
pubmed: 14715361
Cardiovasc J Afr. 2012 Jul;23(6):322-9
pubmed: 22337203
Am J Cardiol. 2007 Jul 15;100(2):302-4
pubmed: 17631087
Eur J Heart Fail. 2019 Jul;21(7):827-843
pubmed: 31243866
Eur J Heart Fail. 2020 Jul;22(7):1097-1107
pubmed: 32243666
Lancet. 2006 Aug 19;368(9536):687-93
pubmed: 16920474
ESC Heart Fail. 2021 Apr;8(2):879-889
pubmed: 33453082
BMJ. 1996 Jan 27;312(7025):222
pubmed: 8563589
Eur Heart J. 2013 Mar;34(9):657-65
pubmed: 22968232
J Am Coll Cardiol. 2012 May 15;59(20):1785-95
pubmed: 22575317
Eur Heart J. 2013 Feb;34(7):529-39
pubmed: 23041499
J Am Heart Assoc. 2016 Jun 17;5(6):
pubmed: 27317349
Br J Gen Pract. 2007 Mar;57(536):191-5
pubmed: 17359605
J Am Heart Assoc. 2016 Mar 25;5(3):e002956
pubmed: 27016575
Int J Cardiol. 2019 Feb 1;276:177-184
pubmed: 30497895
J Cardiovasc Dev Dis. 2015 May 13;2(2):93-107
pubmed: 29371514
J Am Heart Assoc. 2017 Sep 20;6(9):
pubmed: 28931529
Am Heart J. 1949 Feb;37(2):161-86
pubmed: 18107386
Eur J Heart Fail. 2010 Aug;12(8):767-78
pubmed: 20675664
Cell. 2007 Feb 9;128(3):589-600
pubmed: 17289576
Eur Heart J. 2012 Apr;33(7):866-74
pubmed: 22048682
Eur J Heart Fail. 2014 Dec;16(12):1331-6
pubmed: 25371320
Lancet. 2016 May 21;387(10033):2072-2073
pubmed: 27301808
Cardiovasc J Afr. 2016 Mar-Apr;27(2):66-70
pubmed: 27213852
Circ Arrhythm Electrophysiol. 2009 Aug;2(4):427-32
pubmed: 19808499
Am J Obstet Gynecol. 2016 Apr;214(4):527.e1-527.e6
pubmed: 26924745

Auteurs

Amam C Mbakwem (AC)

Department of Medicine, College of Medicine, University of Lagos, Idi Araba, Lagos, Nigeria.

Johann Bauersachs (J)

Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Charle Viljoen (C)

Division of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Hatter Institute for Cardiovascular Research in Africa and Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Julian Hoevelmann (J)

Hatter Institute for Cardiovascular Research in Africa and Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Saarland University Hospital, Homburg/Saar, Germany.

Peter van der Meer (P)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Mark C Petrie (MC)

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.

Alexandre Mebazaa (A)

UMR 942 Inserm - MASCOT; University of Paris; Department of Anesthesia-Burn-Critical Care, APHP Saint Louis Lariboisière University Hospitals, Paris, France.

Sorel Goland (S)

Department of Cardiology, Hebrew University and Hadassah Medical School, Jerusalem, Israel.

Kamilu Karaye (K)

Department of Cardiology, Bayero University, Kano, Nigeria.

Cécile Laroche (C)

ESC, EURObservational Research Programme, Sophia-Antipolis, France.

Karen Sliwa (K)

Division of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Hatter Institute for Cardiovascular Research in Africa and Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH